
Please try another search
By Davit Kirakosyan
Here is your Pro Recap of the biggest analyst picks you may have missed since Friday: upgrades at Dow, Rocket, AstraZeneca, and Coeur Mining.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Dow (NYSE:DOW) shares rose more than 1% pre-market today after JPMorgan upgraded the company to Overweight from Neutral with a price target of $55.00.
The firm noted that Dow has faced challenges such as weaker demand in China and Europe, domestic capacity increases, replenished inventories, and a sluggish global economy. However, the bank believes “the recent downward movement in equity values has given investors an opportunity to purchase Dow shares at a reasonable valuation”.
According to JPMorgan, the company has a robust balance sheet, offers a 5.6% dividend yield, and the potential for positive responses to higher oil prices.
CFRA upgraded Rocket (NYSE:RKT) to Hold from Sell with a price target of $8.00, as reported in real-time on InvestingPro. Shares jumped more than 8% pre-market today.
The firm sees Rocket's fair value closer to its target after a 30% drop from August highs. CFRA maintains its earnings estimates, projecting a loss of $0.15 per share in 2023 and a profit of $0.45 per share in 2024, supported by revenue estimates of $3.97 billion and $5.2B.
Despite challenges in the mortgage market, the firm believes Rocket's diversified businesses and available liquidity resources position it well.
AstraZeneca (NASDAQ:AZN) shares rose more than 1% pre-market today after Jefferies upgraded the company to Buy from Neutral and raised its price target to $80.00 from $66.50.
Last week, the company reported positive high-level results from the TROPION-Breast01 Phase III trial.
RBC Capital upgraded Coeur Mining (NYSE:CDE) to Outperform from Sector Perform with a price target of $4.00. As a result, shares surged more than 7% on Friday.
The expansion at Rochester is almost complete, and execution on the ramp up through mid-2024 is the key catalyst for the stock in our view. The site visit we attended highlighted the +$700m investment in throughput expansion, which should lead to +120% higher production once at full capacity in 2025.
In fast-moving markets, every second counts - and InvestingPro subscribers are always one step ahead with lightning-quick updates.
Start your free 7-day trial now.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.